Pseudomonas aeruginosa LecB is involved in pilus biogenesis and protease IV activity but not in adhesion to respiratory mucins.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 1698087)

Published in Infect Immun on October 02, 2006

Authors

Avinash Sonawane1, Jeevan Jyot, Reuben Ramphal

Author Affiliations

1: Department of Medicine, College of Medicine, 1600 SW Archer Road, Gainesville, FL 32610, USA.

Articles citing this

Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun (2009) 1.26

In vitro and in vivo characterization of the Pseudomonas aeruginosa cyclic AMP (cAMP) phosphodiesterase CpdA, required for cAMP homeostasis and virulence factor regulation. J Bacteriol (2010) 1.17

The sigma factor AlgU plays a key role in formation of robust biofilms by nonmucoid Pseudomonas aeruginosa. J Bacteriol (2010) 1.02

Detection and characterization of a sialoglycosylated bacterial ABC-type phosphate transporter protein from patients with visceral leishmaniasis. Glycoconj J (2009) 0.91

Engineering of PA-IIL lectin from Pseudomonas aeruginosa - Unravelling the role of the specificity loop for sugar preference. BMC Struct Biol (2007) 0.87

Glycosylation is required for outer membrane localization of the lectin LecB in Pseudomonas aeruginosa. J Bacteriol (2011) 0.84

Specific association of lectin LecB with the surface of Pseudomonas aeruginosa: role of outer membrane protein OprF. PLoS One (2012) 0.80

The Pseudomonas aeruginosa periplasmic protease CtpA can affect systems that impact its ability to mount both acute and chronic infections. Infect Immun (2013) 0.79

Development of a Novel Method for Analyzing Pseudomonas aeruginosa Twitching Motility and Its Application to Define the AmrZ Regulon. PLoS One (2015) 0.76

Pseudomonas Aeruginosa Lectins As Targets for Novel Antibacterials. Acta Naturae (2015) 0.75

Engineering the Pseudomonas aeruginosa II lectin: designing mutants with changed affinity and specificity. J Comput Aided Mol Des (2014) 0.75

Articles cited by this

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30

Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol (1998) 17.38

Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol (1998) 17.18

Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19

Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene (1986) 13.92

Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol (2003) 5.31

PRODUCTION OF ELASTASE AND PROTEINASE BY PSEUDOMONAS AERUGINOSA. J Bacteriol (1964) 4.40

The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol (1997) 4.07

The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease. J Infect Dis (1966) 3.69

Pseudomonas aeruginosa exotoxin: effect on cell cultures. J Infect Dis (1972) 3.63

Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol Microbiol (1996) 3.55

Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK. J Bacteriol (1990) 3.01

The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers. J Infect Dis (1990) 2.98

Protein secretion in Pseudomonas aeruginosa: characterization of seven xcp genes and processing of secretory apparatus components by prepilin peptidase. Mol Microbiol (1992) 2.39

The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect Immun (1998) 2.29

Structural basis for oligosaccharide-mediated adhesion of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients. Nat Struct Biol (2002) 2.12

Adhesion of Pseudomonas aeruginosa pilin-deficient mutants to mucin. Infect Immun (1991) 2.06

Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa. Mol Microbiol (2004) 1.65

Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg (2000) 1.62

Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology (2005) 1.59

Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect Immun (2001) 1.56

A novel type II secretion system in Pseudomonas aeruginosa. Mol Microbiol (2002) 1.54

The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut-derived sepsis. Ann Surg (2000) 1.21

Pseudomonas aeruginosa exhibits directed twitching motility up phosphatidylethanolamine gradients. J Bacteriol (2001) 1.21

The sugar code: functional lectinomics. Biochim Biophys Acta (2002) 1.14

Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonas proteases. Anal Biochem (2001) 1.13

The intracellular localization of Pseudomonas aeruginosa lectins. J Gen Microbiol (1983) 1.11

Biological activities of carbohydrate-branched chitosan derivatives. Biomacromolecules (2001) 0.91

Application of zwitterionic detergents to the solubilization of integral membrane proteins for two-dimensional gel electrophoresis and mass spectrometry. Proteomics (2002) 0.84

Articles by these authors

MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48

Critical role for Ipaf in Pseudomonas aeruginosa-induced caspase-1 activation. Eur J Immunol (2007) 4.19

A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol (2003) 3.05

Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc Natl Acad Sci U S A (2004) 1.58

Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J Immunol (2010) 1.54

Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol (2008) 1.45

Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections. Infect Immun (2005) 1.43

Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum. Am J Respir Crit Care Med (2013) 1.42

Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect Immun (2005) 1.38

FleQ, the major flagellar gene regulator in Pseudomonas aeruginosa, binds to enhancer sites located either upstream or atypically downstream of the RpoN binding site. J Bacteriol (2002) 1.36

fleQ, the gene encoding the major flagellar regulator of Pseudomonas aeruginosa, is sigma70 dependent and is downregulated by Vfr, a homolog of Escherichia coli cyclic AMP receptor protein. J Bacteriol (2002) 1.36

Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One (2009) 1.35

The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J Infect Dis (2007) 1.26

Sequence polymorphism in the glycosylation island and flagellins of Pseudomonas aeruginosa. J Bacteriol (2004) 1.23

Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. J Immunol (2011) 1.21

Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions. J Leukoc Biol (2005) 1.12

Glycosylation of b-Type flagellin of Pseudomonas aeruginosa: structural and genetic basis. J Bacteriol (2006) 1.12

Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing. Proc Natl Acad Sci U S A (2012) 1.05

Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in Pseudomonas aeruginosa. Infect Immun (2006) 0.97

Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway. PLoS One (2010) 0.96

Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus. Mol Microbiol (2007) 0.95

Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepacia. J Immunol (2009) 0.94

Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J Infect Dis (2011) 0.94

Expression of surfactant protein D in human corneal epithelial cells is upregulated by Pseudomonas aeruginosa. FEMS Immunol Med Microbiol (2008) 0.93

Thrombocytopenia secondary to linezolid administration: what is the risk? Clin Infect Dis (2002) 0.93

Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa. Infect Immun (2013) 0.92

A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosa. PLoS One (2012) 0.85

Time to positivity of blood cultures supports antibiotic de-escalation at 48 hours. Ann Pharmacother (2013) 0.84

Exchangeability of the flagellin (FliC) and the cap protein (FliD) among different species in flagellar assembly. Biopolymers (2013) 0.83

Flagellin concentrations in expectorations from cystic fibrosis patients. BMC Pulm Med (2014) 0.78

Measuring quality metrics to identify and monitor antimicrobial stewardship program quality improvement efforts. Infect Control Hosp Epidemiol (2014) 0.75

Extended-spectrum beta-lactamases. Semin Respir Infect (2002) 0.75

Basic research funding by philanthropic organizations: a case in point. Am J Respir Crit Care Med (2013) 0.75